Piramal Pharma(PPLPHARMA.NS)
Focus: Piramal Pharma is a mid-cap public CDMO and specialty pharma company headquartered in Mumbai, India, with 5,001-10,000 employees. The company generates significant revenue from branded and generic pharmaceuticals, with heavy dependence on its commercial portfolio.
Profile data last refreshed 16h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Employees
5001-10000
Open Jobs
0
About Piramal Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Piramal Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Piramal Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$139K Part DStable
Peak11.2yr
Anchors 47% of company revenue; patent protection until 2038 provides long-term cash generation, but creates company-wide dependency risk.
Help build intelligence for Piramal Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.